(Reuters) - Valeant Pharmaceuticals International Inc's U.S.-listed stock fell about 10 percent in premarket trading on Thursday after the Wall Street Journal reported that prosecutors had opened a criminal investigation into the Canadian drugmaker.

Valeant stock falls on report of criminal probe
Read More
Bagikan Berita Ini
0 Response to "Valeant stock falls on report of criminal probe"
Posting Komentar